IBM Climbs as Quantum Investment Momentum and an Analyst Upgrade Lift Sentiment

International Business Machines (IBM) is up 7.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be a combination of stronger enthusiasm around IBM’s quantum computing position and a favorable analyst rating change that improved sentiment toward its software outlook. This could also reflect investors looking past IBM’s midyear stumble and repositioning around longer-term AI, infrastructure, and quantum catalysts.

Details:

IBM announced plans in June to invest more than $10 billion in quantum computing over five years, reinforcing its push toward fault-tolerant systems and strengthening its long-term technology narrative.

The U.S. Commerce Department outlined planned support for a new IBM quantum foundry, adding a government-backed angle that may have increased confidence in IBM’s strategic role in domestic advanced computing.

A major Wall Street firm upgraded IBM to Overweight and raised its price target, pointing to expectations for stronger software growth and a business mix that could justify a higher valuation.

Recent gains may also reflect a rebound from the sharp selloff that followed IBM’s weaker preliminary second-quarter update, as investors rotate back into names tied to enterprise AI and next-generation infrastructure.

Sources:

IBM, NIST, Yahoo Finance

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$IBM Insider Trading Activity

$IBM insiders have traded $IBM stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $IBM stock by insiders over the last 6 months:

ROBERT DAVID THOMAS (Senior Vice President) sold 25,000 shares for an estimated $5,758,087

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$IBM Hedge Fund Activity

We have seen 1,822 institutional investors add shares of $IBM stock to their portfolio, and 1,491 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 12,445,411 shares (+inf%) to their portfolio in Q2 2026, for an estimated $3,499,774,027
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 7,132,137 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,005,628,245
WELLINGTON MANAGEMENT GROUP LLP added 6,283,395 shares (+2362.2%) to their portfolio in Q2 2026, for an estimated $1,766,953,507
VICTORY CAPITAL MANAGEMENT INC removed 2,369,959 shares (-51.7%) from their portfolio in Q2 2026, for an estimated $666,456,170
FMR LLC added 2,187,458 shares (+41.7%) to their portfolio in Q2 2026, for an estimated $615,135,064
MORGAN STANLEY removed 2,171,123 shares (-11.1%) from their portfolio in Q2 2026, for an estimated $610,541,498
BANK OF NEW YORK MELLON CORP added 2,099,174 shares (+29.3%) to their portfolio in Q2 2026, for an estimated $590,308,720

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$IBM Government Contracts

We have seen $1,188,962,013 of award payments to $IBM over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

BENEFITS TRANSFORMATION PLATFORM: $134,809,706
SUSTAINMENT, ENHANCEMENT AND TRANSITION SUPPORT OF VAS ENTERPRISE CORE HR SOLUTION - HRSMART. THE CONTRACT...: $72,039,310
DEVELOPMENT, SECURITY, AND OPERATIONS (DEVSECOPS) SERVICES TO SUPPORT UNITED STATES CITIZENSHIP AND IMMIGRA...: $65,151,545
NAVY ENTERPRISE RESOURCE PLANNING (ERP) TECHNICAL SUPPORT SERVICES (NETSS).: $48,248,428
MODERNIZED E-FILE (MEF): $46,814,864

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$IBM Congressional Stock Trading

Members of Congress have traded $IBM stock 15 times in the past 6 months. Of those trades, 5 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $IBM stock by members of Congress over the last 6 months:

REPRESENTATIVE LLOYD DOGGETT has traded it 2 times. They made 2 purchases worth up to $30,000 on 09/10, 06/10 and 0 sales.
REPRESENTATIVE MARIA ELVIRA SALAZAR has traded it 6 times. They made 2 purchases worth up to $100,000 on 05/21 and 4 sales worth up to $60,000 on 09/04, 08/24.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 08/18 and 2 sales worth up to $65,000 on 07/17, 05/15.
REPRESENTATIVE JOSH GOTTHEIMER has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 07/16, 07/15, 04/24.
REPRESENTATIVE MATTHEW VAN EPPS sold up to $15,000 on 06/16.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$IBM Price Targets

Multiple analysts have issued price targets for $IBM recently. We have seen 8 analysts offer price targets for $IBM in the last 6 months, with a median target of $310.0.

Here are some recent targets:

Wamsi Mohan from B of A Securities set a target price of $330.0 on 07/06/2026
Brian Essex from JP Morgan set a target price of $291.0 on 06/23/2026
Erik Woodring from Morgan Stanley set a target price of $267.0 on 06/23/2026
Fatima Boolani from Citigroup set a target price of $375.0 on 06/03/2026
Raimo Lenschow from Barclays set a target price of $350.0 on 06/01/2026
Dan Ives from Wedbush set a target price of $320.0 on 05/29/2026
Matthew Swanson from RBC Capital set a target price of $300.0 on 05/06/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.